358
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 2261-2263 | Received 31 Oct 2017, Accepted 26 Dec 2017, Published online: 11 Jan 2018

References

  • Naik H, Lockwood S, Saavedra A. A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis. J Cutan Pathol. 2017;44:857–860.
  • Macedo FI, Faris J, Lum LG, et al. Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management. J Burn Care Res. 2014;35: e431–e435.
  • Alkemade JA, Molhuizen HO, Ponec M, et al. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci 1994;107: 2335–2342.
  • Van bergen BH, Andriessen MP, Spruijt KI, et al. Expression of SKALP/elafin during wound healing in human skin. Arch Dermatol Res. 1996;288:458–462.
  • Paczesny S, Braun TM, Levine JE, et al. Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med. 2010;2:13ra2
  • Yang C, Mosam A, Mankahla A, et al. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells. J Am Acad Dermatol. 2014;70: 1096–1102.
  • Min SS, Mehra V, Clay J, et al. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants—single centre pilot study. J Clin Pathol. 2017;70:886–890.
  • Brüggen MC, Petzelbauer P, Greinix H, et al. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease. J Invest Dermatol. 2015;135: 999–1006.
  • Metafuni E, Giammarco S, Deritis DG, et al. Changes in protein serum levels during stem cell transplantation. Eur J Clin Invest. 2017;47:711–718.
  • Levine JE, Logan BR, Wu J, et al. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a blood and marrow transplant clinical trials network study. Blood. 2012;119:3854–3860.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.